Shi Jian, Li Xiao-hua, Sun Bei-cheng, Lin Xu-tao, Zhang Xing-yuan, Zhang Fan, Ou Kun, Chen Qiang-pu
Affiliated Hospital, Binzhou Medical College, Shandong Province, Binzhou 256603, China.
Zhonghua Yi Xue Za Zhi. 2011 Oct 18;91(38):2719-24.
To explore the protective functions of recombinant protein RANK-Fc against hepatic ischemia/reperfusion injury and clarify its possible mechanism.
Sixty male Balb/c mice were randomly divided into 3 groups according to different treatments: serum-free medium control (Sham) group, target gene retrovirus (RANK-Fc) group and empty vector retrovirus (eGFP) group. All mice were injected with 2.5 ml solution (with or without retrovirus) within 6 seconds via tail vein. After 3 days, the model of 70% hepatic ischemia/reperfusion was induced under warm conditions for 90 minutes after different periods of reperfusion in RANK-Fc and eGFP groups; Sham group underwent the same procedure without the occlusion of blood supply. Blood and liver samples were obtained at different time points (1, 3, 6 and 24 h; n = 5 in each). Reverse transcription-polymerase chain reaction (RT-PCR) was used for the evaluation of eGFP mRNA expression. RANK-Fc was assessed by Western blot. Liver transaminases and histopathological changes were used for the evaluation of hepatic injury. The activity of NF-κB in liver nucleus was analyzed by Western blot and immunohistochemistry. The activation level of JNK was also assessed by Western blot. Liver homogenate levels of tumor necrosis factor (TNF)-α and interleukin (IL)-6 were detected by enzyme-linked immunosorbent assay (ELISA). Apoptosis was identified by the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) analysis. The differences between three treatment groups at each time point were detected by the one-way ANOVA. Statistical analysis for inter-comparison was performed by Student's t test.
RANK-Fc and eGFP were successfully expressed in liver after hydrodynamics-based transfection. Compared with eGFP group, RANK-Fc significantly improved liver functions at the same time point (P < 0.01), decreased NF-κB nuclear translocation (t = 6.726, P < 0.01)and JNK phosphorylation (t = 6.713, P < 0.01)and obviously suppressed the release of pro-inflammatory cytokine TNF-α (t = 4.779, P < 0.01) and IL-6 (t = 5.482, P < 0.01). Morphological injuries were markedly alleviated while the expressions of immunohistochemical positive cells and TUNEL staining positive cells decreased in RANF-Fc group.
RANK-Fc has protective functions against hepatic ischemia/reperfusion injury in mice. Its mechanism is at least partially related with the suppressions of proinflammatory NF-κB and proapoptotic JNK signaling pathways.
探讨重组蛋白RANK-Fc对肝脏缺血/再灌注损伤的保护作用,并阐明其可能机制。
60只雄性Balb/c小鼠根据不同处理随机分为3组:无血清培养基对照组(假手术组)、靶基因逆转录病毒(RANK-Fc)组和空载体逆转录病毒(eGFP)组。所有小鼠均经尾静脉在6秒内注射2.5 ml溶液(含或不含逆转录病毒)。3天后,RANK-Fc组和eGFP组在不同再灌注时间后于温暖条件下诱导70%肝脏缺血/再灌注模型90分钟;假手术组进行相同操作但不阻断血供。在不同时间点(1、3、6和24小时;每组n = 5)采集血液和肝脏样本。采用逆转录-聚合酶链反应(RT-PCR)评估eGFP mRNA表达。通过蛋白质印迹法检测RANK-Fc。采用肝转氨酶和组织病理学变化评估肝损伤。通过蛋白质印迹法和免疫组织化学分析肝细胞核中NF-κB的活性。JNK的激活水平也通过蛋白质印迹法进行评估。采用酶联免疫吸附测定(ELISA)检测肝匀浆中肿瘤坏死因子(TNF)-α和白细胞介素(IL)-6的水平。通过末端脱氧核苷酸转移酶dUTP缺口末端标记(TUNEL)分析鉴定细胞凋亡。采用单因素方差分析检测三个处理组在每个时间点的差异。采用Student's t检验进行组间比较的统计分析。
基于流体动力学的转染后,RANK-Fc和eGFP在肝脏中成功表达。与eGFP组相比,RANK-Fc在同一时间点显著改善肝功能(P < 0.01), 减少NF-κB核转位(t = 6.726,P < 0.01)和JNK磷酸化(t = 6.713,P < 0.01),并明显抑制促炎细胞因子TNF-α(t = 4.779,P < 0.01)和IL-6(t = 5.482,P < 0.01)的释放。RANK-Fc组形态学损伤明显减轻, 免疫组织化学阳性细胞和TUNEL染色阳性细胞的表达减少。
RANK-Fc对小鼠肝脏缺血/再灌注损伤具有保护作用。其机制至少部分与抑制促炎NF-κB和促凋亡JNK信号通路有关。